ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Merck & Co., Inc., AbbVie, PepsiCo, Gilead Sciences, and Texas Instruments are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
NASDAQ SQQQ traded down $1.07 during trading on Friday, hitting $31.65. The stock had a trading volume of 108,625,712 shares, compared to its average volume of 49,545,027. ProShares UltraPro Short QQQ has a twelve month low of $26.21 and a twelve month high of $61.60. The firm has a 50 day moving average price of $36.54 and a 200 day moving average price of $33.21.
Read Our Latest Research Report on SQQQ
Direxion Daily TSLA Bull 2X Shares (TSLL)
TSLL stock traded up $1.71 during midday trading on Friday, hitting $10.45. The company's stock had a trading volume of 264,295,819 shares, compared to its average volume of 83,698,267. The firm has a 50-day simple moving average of $10.26 and a 200-day simple moving average of $18.23. The firm has a market capitalization of $5.48 billion, a P/E ratio of 48.19 and a beta of -5.14. Direxion Daily TSLA Bull 2X Shares has a 52-week low of $6.29 and a 52-week high of $41.50.
Read Our Latest Research Report on TSLL
Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
NYSE:MRK traded up $2.99 during midday trading on Friday, reaching $82.83. The company had a trading volume of 28,374,477 shares, compared to its average volume of 11,891,688. The stock's fifty day simple moving average is $87.05 and its 200-day simple moving average is $95.23. The company has a current ratio of 1.36, a quick ratio of 1.15 and a debt-to-equity ratio of 0.79. Merck & Co., Inc. has a 12-month low of $75.93 and a 12-month high of $134.63. The firm has a market capitalization of $208.88 billion, a price-to-earnings ratio of 12.31, a PEG ratio of 0.77 and a beta of 0.40.
Read Our Latest Research Report on MRK
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
Shares of ABBV traded up $5.59 during midday trading on Friday, hitting $185.96. The company had a trading volume of 10,480,961 shares, compared to its average volume of 6,064,215. AbbVie has a 1 year low of $153.58 and a 1 year high of $218.66. The firm has a market capitalization of $328.96 billion, a P/E ratio of 77.48, a P/E/G ratio of 1.62 and a beta of 0.55. The company has a debt-to-equity ratio of 17.94, a quick ratio of 0.55 and a current ratio of 0.66. The company's 50-day simple moving average is $196.85 and its 200-day simple moving average is $187.23.
Read Our Latest Research Report on ABBV
PepsiCo (PEP)
PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
PepsiCo stock traded down $1.93 during trading on Friday, reaching $133.38. The stock had a trading volume of 11,537,466 shares, compared to its average volume of 6,145,927. The company has a quick ratio of 0.65, a current ratio of 0.82 and a debt-to-equity ratio of 2.05. PepsiCo has a 52-week low of $131.80 and a 52-week high of $183.41. The stock has a market cap of $182.91 billion, a PE ratio of 19.19, a P/E/G ratio of 3.09 and a beta of 0.49. The business has a 50 day moving average price of $147.70 and a 200 day moving average price of $153.92.
Read Our Latest Research Report on PEP
Gilead Sciences (GILD)
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.
Shares of GILD traded down $2.98 during midday trading on Friday, reaching $103.17. The stock had a trading volume of 14,207,970 shares, compared to its average volume of 7,526,289. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.50 and a quick ratio of 1.20. The company's fifty day simple moving average is $109.21 and its two-hundred day simple moving average is $98.15. The company has a market cap of $128.46 billion, a price-to-earnings ratio of 278.84, a PEG ratio of 0.71 and a beta of 0.32. Gilead Sciences has a 1-year low of $62.07 and a 1-year high of $119.96.
Read Our Latest Research Report on GILD
Texas Instruments (TXN)
Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers in the United States and internationally. The company operates through Analog and Embedded Processing segments. The Analog segment offers power products to manage power requirements across various voltage levels, including battery-management solutions, DC/DC switching regulators, AC/DC and isolated controllers and converters, power switches, linear regulators, voltage references, and lighting products.
Texas Instruments stock traded up $0.73 during midday trading on Friday, reaching $162.86. The company's stock had a trading volume of 8,381,928 shares, compared to its average volume of 6,190,720. The company has a market cap of $148.19 billion, a P/E ratio of 31.38, a P/E/G ratio of 3.30 and a beta of 0.99. The company has a quick ratio of 2.88, a current ratio of 4.12 and a debt-to-equity ratio of 0.76. The business has a 50-day simple moving average of $174.21 and a 200-day simple moving average of $187.82. Texas Instruments has a fifty-two week low of $139.95 and a fifty-two week high of $220.39.
Read Our Latest Research Report on TXN
Featured Stories
Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.
While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
